HTLV-1 Tax-1 interacts with SNX27 to regulate cellular localization of the HTLV-1 receptor molecule, GLUT1.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 04 10 2018
accepted: 06 03 2019
entrez: 22 3 2019
pubmed: 22 3 2019
medline: 18 12 2019
Statut: epublish

Résumé

An estimated 10-20 million people worldwide are infected with human T cell leukemia virus type 1 (HTLV-1), with endemic areas of infection in Japan, Australia, the Caribbean, and Africa. HTLV-1 is the causative agent of adult T cell leukemia (ATL) and HTLV-1 associated myopathy/tropic spastic paraparesis (HAM/TSP). HTLV-1 expresses several regulatory and accessory genes that function at different stages of the virus life cycle. The regulatory gene Tax-1 is required for efficient virus replication, as it drives transcription of viral gene products, and has also been demonstrated to play a key role in the pathogenesis of the virus. Several studies have identified a PDZ binding motif (PBM) at the carboxyl terminus of Tax-1 and demonstrated the importance of this domain for HTLV-1 induced cellular transformation. Using a mass spectrometry-based proteomics approach we identified sorting nexin 27 (SNX27) as a novel interacting partner of Tax-1. Further, we demonstrated that their interaction is mediated by the Tax-1 PBM and SNX27 PDZ domains. SNX27 has been shown to promote the plasma membrane localization of glucose transport 1 (GLUT1), one of the receptor molecules of the HTLV-1 virus, and the receptor molecule required for HTLV-1 fusion and entry. We postulated that Tax-1 alters GLUT1 localization via its interaction with SNX27. We demonstrate that over expression of Tax-1 in cells causes a reduction of GLUT1 on the plasma membrane. Furthermore, we show that knockdown of SNX27 results in increased virion release and decreased HTLV-1 infectivity. Collectively, we demonstrate the first known mechanism by which HTLV-1 regulates a receptor molecule post-infection.

Identifiants

pubmed: 30897179
doi: 10.1371/journal.pone.0214059
pii: PONE-D-19-06509
pmc: PMC6428263
doi:

Substances chimiques

Gene Products, tax 0
Glucose Transporter Type 1 0
Receptors, Virus 0
SLC2A1 protein, human 0
SNX27 protein, human 0
Sorting Nexins 0
gag Gene Products, Human Immunodeficiency Virus 0
p19 protein, Human T-lymphotropic virus 1 0
tax protein, Human T-lymphotrophic virus 1 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0214059

Subventions

Organisme : NCI NIH HHS
ID : P01 CA100730
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA063417
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Blood. 1995 Dec 1;86(11):4243-9
pubmed: 7492783
Front Biosci. 2004 Sep 01;9:2852-9
pubmed: 15353320
Cancer Sci. 2013 Mar;104(3):313-20
pubmed: 23279616
IUBMB Life. 2010 May;62(5):315-33
pubmed: 20209635
J Biol Chem. 2005 Aug 12;280(32):29025-9
pubmed: 15955807
Viruses. 2011 Jun;3(6):794-810
pubmed: 21994754
Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):E3604-13
pubmed: 25136126
J Virol. 2007 Nov;81(21):11900-7
pubmed: 17715223
Nat Rev Mol Cell Biol. 2008 Jul;9(7):574-82
pubmed: 18523436
Front Microbiol. 2013 Aug 15;4:231
pubmed: 23966989
J Biol Chem. 2015 Oct 23;290(43):26270-81
pubmed: 26324707
Virology. 2004 Mar 1;320(1):52-62
pubmed: 15003862
Oncogene. 1998 Feb 5;16(5):643-54
pubmed: 9482110
J Virol. 2005 Dec;79(23):14473-81
pubmed: 16282446
Virology. 2003 Jul 5;311(2):316-25
pubmed: 12842621
J Virol. 2015 Oct;89(20):10145-55
pubmed: 26202251
Mol Cell Biol. 1997 Sep;17(9):5156-64
pubmed: 9271393
J Virol. 2003 Sep;77(18):9922-30
pubmed: 12941902
Br J Haematol. 1991 Nov;79(3):428-37
pubmed: 1751370
Blood. 1984 Aug;64(2):482-90
pubmed: 6331549
Clin Microbiol Rev. 2010 Jul;23(3):577-89
pubmed: 20610824
Nat Cell Biol. 2013 May;15(5):461-71
pubmed: 23563491
Int J Hematol. 1997 Oct;66(3):257-78
pubmed: 9401272
Methods Mol Biol. 2017;1582:47-55
pubmed: 28357661
J Biol Chem. 2007 Nov 9;282(45):33132-41
pubmed: 17855372
Blood. 1988 Feb;71(2):363-9
pubmed: 2827811
Nat Struct Mol Biol. 2016 Oct;23(10):921-932
pubmed: 27595347
Retrovirology. 2012 Aug 09;9:64
pubmed: 22876852
Virology. 1994 Nov 1;204(2):656-64
pubmed: 7941334
Lancet. 2018 May 12;391(10133):1893-1894
pubmed: 29781438
J Biol Chem. 1993 Oct 5;268(28):21225-31
pubmed: 8407959
Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9
pubmed: 6261256
Blood. 2006 Mar 1;107(5):1980-8
pubmed: 16263794
Front Microbiol. 2012 Nov 30;3:406
pubmed: 23226145
J Virol. 2004 Oct;78(20):11077-83
pubmed: 15452228
Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6670-5
pubmed: 9192623
Mol Cell Biol. 1994 Feb;14(2):1374-82
pubmed: 8289813
J Virol. 2006 Oct;80(20):10036-44
pubmed: 17005681
Retrovirology. 2005 Jul 23;2:46
pubmed: 16042787
Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1057-61
pubmed: 7862633
Virus Genes. 2010 Apr;40(2):193-9
pubmed: 20069350
J Virol. 2015 Jan;89(1):502-11
pubmed: 25339765
Curr HIV Res. 2004 Jan;2(1):51-9
pubmed: 15053340
Proc Natl Acad Sci U S A. 1982 Mar;79(6):2031-5
pubmed: 6979048
J Virol. 2006 Jul;80(14):6844-54
pubmed: 16809290

Auteurs

Jacob Al-Saleem (J)

Center for Retrovirus Research, The Ohio State University, Columbus, Ohio, United States of America.
Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, United States of America.

Wessel P Dirksen (WP)

Center for Retrovirus Research, The Ohio State University, Columbus, Ohio, United States of America.
Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, United States of America.

Michael P Martinez (MP)

Center for Retrovirus Research, The Ohio State University, Columbus, Ohio, United States of America.
Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, United States of America.

Nikoloz Shkriabai (N)

Division of Infectious Diseases, School of Medicine, University of Colorado Denver, Aurora, Colorado, United States of America.

Mamuka Kvaratskhelia (M)

Division of Infectious Diseases, School of Medicine, University of Colorado Denver, Aurora, Colorado, United States of America.

Lee Ratner (L)

Division of Oncology, Washington University, St Louis, Missouri, United States of America.

Patrick L Green (PL)

Center for Retrovirus Research, The Ohio State University, Columbus, Ohio, United States of America.
Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, United States of America.
Comprehensive Cancer Center and Solove Research Institute, The Ohio State University, Columbus, Ohio, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH